Fractions with a purity of greater than 95% were pooled and lyophilized
Research Background FOXO4-DRI has been studied in preclinical senescence research for its proposed ability to selectively induce apoptosis in senescent cells by disrupting FOXO4-p53 binding
Kuhre RE, Ghiasi SM, Adriaenssens AE, et al
This medication can also be beneficial for individuals with specific underlying medical conditions contributing to weight gain, such as Cushings syndrome, hypothyroidism, or certain genetic disorders
[15], [16] Epithalon appears to help maintain and improve the normal structure of the eye retina condition while increasing the bioelectric and functional activity of the retina due to the preservation of its morphological structure
However, better depends on individual priorities